The basic mechanism by which PDIT works is through the use of a photosensitizing agent delivered to the breast tumor that, when exposed to a unique wavelength of light, causes one of the oxygen molecules to spin in the opposite direction in an ever increasing arc before it returns home.
PDIT is designed to harness the energy of singlet oxygen to defeat cancer cells without serious side effects while amplifying the immune system.
When PDIT is applied to primary breast tumor(s), it neutralizes cancer cells and shrinks and destroys tumors by damaging the cell walls and blood vessels in the tumors, thus making it impossible for the tumor to receive nutrients.
PDIT also activates the immune system by breaking down the cancer cells' RNA and exposing tumor cells' immune signal, i.e., antigens.
An Adaptive Immune Response does not occur with conventional chemotherapy or radiation so by choosing PDIT, many patients are able to avoid surgery, radiation, and chemotherapy.
PDIT is an outpatient procedure that can be performed once or more as required depending on individual response to the treatment.